| Rachel I Mandel, MD | |
|
75 Thomas Johnson Drive, Suite J, Frederick, MD 21702-4895 | |
| (301) 620-0010 | |
| (301) 682-3977 |
| Full Name | Rachel I Mandel |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 75 Thomas Johnson Drive, Frederick, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427030170 | NPI | - | NPPES |
| 15050 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D0047236 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel I Mandel, MD 75 Thomas Johnson Drive, Suite J, Frederick, MD 21702-4895 Ph: (301) 620-0010 | Rachel I Mandel, MD 75 Thomas Johnson Drive, Suite J, Frederick, MD 21702-4895 Ph: (301) 620-0010 |
News Archive
Endo Pharmaceuticals today reported financial results for the second quarter 2010. Total revenues during the second quarter of 2010 increased 6 percent to $396.5 million, compared with $373.1 million in the same quarter of 2009. Net income for the three months ended June 30, 2010 was $51.5 million, compared with $30.0 million in the comparable 2009 period.
TriReme Medical, Inc. announced today that it has received FDA clearance for an expanded matrix of sizes for its Chocolate PTA balloon catheter. Chocolate is now approved for the percutaneous transluminal treatment of lesions in the peripheral vasculature in balloon diameters from 2.0 - 4.0mm and in balloon lengths up to 120mm.
The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic diseases.
Researchers from MIT and Massachusetts General Hospital have developed an automated model that assesses dense breast tissue in mammograms - which is an independent risk factor for breast cancer - as reliably as expert radiologists.
Researchers funded by the National Institutes of Health have identified a new immune disorder-DOCK2 deficiency-named after the mutated gene responsible for the disease.
› Verified 4 days ago
Gerardo G Araiza, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 61 Thomas Johnson Dr, Frederick, MD 21702 Phone: 301-663-6171 Fax: 301-695-4469 | |
Dr. Richard Gareth Holz, M.D, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 174 Thomas Johnson Dr, Suite 204, Frederick, MD 21702 Phone: 301-662-2300 Fax: 301-662-7364 | |
Tasscia M Williams Souffrant, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 61 Thomas Johnson Dr, Frederick, MD 21702 Phone: 301-663-6171 Fax: 301-695-4469 | |
Analeta Njema Peterson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 61 Thomas Johnson Dr, Frederick, MD 21702 Phone: 301-663-6171 Fax: 301-695-4469 | |
Gerrit Schipper, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 61 Thomas Johnson Dr, Frederick, MD 21702 Phone: 301-663-6171 Fax: 301-695-4469 | |
Dr. Edwin T. Chen, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 97 Thomas Johnson Dr, Suite 101, Frederick, MD 21702 Phone: 301-663-4545 Fax: 301-663-1709 | |
Leonard E Bienkowski, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 61 Thomas Johnson Dr, Frederick, MD 21702 Phone: 301-663-6171 Fax: 301-695-4469 |